In a subsequent study, the authors assessed parafibromin immunoreactivity in a set of parathyroid tumours using monoclonal and polyclonal parafibromin antibodies targeting diverse epitopes scattered across the protein, including the previously used monoclonal parafibromin antibody 2H1 [22]. Here, CDC73 is linked to tumor of parathyroid gland.